SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2759)4/23/2010 1:02:46 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
KERX is bouncing up from the $4 level as it seems that it wants to test the resistance from its Apr15 H at the $4.99 level <g>

The stock hasn't closed its Apr12 UG.
The stock is up 8.76% on volume of > 1.8M is > half its ADV

bigcharts.marketwatch.com

KERX had 4Qs of better revenues. It was able to report on the black in 2009 with the help of the good report on the 2ndQ

It has been helped lately with mentions on articles on the WST Transcript, Motley Fool and Rothman Research.
It also announced this month that it has started a PIII of KRX-1401 for advanced colon Ca.

But losses on the range of $0.34 & $0.36 are expected for 2010 & 2011. KERX has negligible LTD and has +LFCF <g>

As mentioned, the stock is starting to get off from its longer term DT coming from the March 2006 H at $19.35

bigcharts.marketwatch.com

Bernard